Kit for the determination of genetic polymorphisms associated with the risk of severe respiratory infection COVID-19 caused by the SARS-CoV-2 virus
Manufacturer: Sistema- BioTech
SBT-PRO-VI
Kit for the determination of genetic polymorphisms associated with the risk of severe respiratory infection COVID-19 caused by the SARS-CoV-2 virus
The kit is designed for genotyping human DNA for 10 polymorphisms in order to identify genotypes associated with the risk of severe COVID-19.
The matrix for setting up PCR is human genomic DNA isolated from peripheral blood or other biological material (for example, buccal epithelium).
Use:
This test assesses the likelihood of severity of respiratory viral infections, including SARS-CoV-2 coronavirus infection. Regardless of whether or not a person has antibodies to a viral agent, there still remains likelihood of getting sick. As practice has already shown, the course of the disease can vary in different cases. The risks of complications, the development of post-COVID syndrome remain, and, depending on the final risk assessment, the treatment strategy can be changed.
Advantages:
- 8 points - genetic targets.
- This genetic test has no analogues in the Russian Federation.
- The duration of the test is from 1 hour.
- It is possible to quickly gain an understanding of the treatment tactics from the first moment of obtaining the result.
Special Features of the genetic test for coronavirus:
- Beneficial for doctor and patient.
- The ability to quickly assess the severity of the disease and the risks of complications.
- The information obtained during the genetic study does not change throughout life, and the result displayed in the final report of the patient is also relevant in the case of subsequent cases of respiratory infection, including all variations of the coronavirus strains.
- Master mix for PCR-1 — 2700 µl (2 tubes of 1350 µl)
- Master mix for PCR-2 — 320 µl (1 tube)
- Water without nucleases — 2100 µl (2 tubes of 1050 µl)
- Primer Mix #1 for Polymorphism Analysis #1 — 55 µl (1 tube)
- Primer Mix #2 for Polymorphism Analysis #2 — 55 µl (1 tube)
- Primer Mix #3 for Polymorphism Analysis #3 — 55 µl (1 tube)
- Primer Mix #4 for Polymorphism Analysis #4 — 55 µl (1 tube)
- Primer Mix #5 for Polymorphism Analysis #5 — 55 µl (1 tube)
- Primer Mix #6 for Polymorphism Analysis #6 — 55 µl (1 tube)
- Primer Mix #7 for Polymorphism Analysis #7 — 55 µl (1 tube)
- Primer Mix #8 for Polymorphism Analysis #8 — 55 µl (1 tube)
- Primer Mix #9 for Polymorphism Analysis #9 — 55 µl (1 tube)
- Primer Mix #10 for Polymorphism Analysis #10 — 55 µl (1 tube)
The kit contents
Kit for the determination of genetic polymorphisms associated with the risk of severe respiratory infection COVID-19 caused by the SARS-CoV-2 virus
The kit is designed for genotyping human DNA for 10 polymorphisms in order to identify genotypes associated with the risk of severe COVID-19.
The matrix for setting up PCR is human genomic DNA isolated from peripheral blood or other biological material (for example, buccal epithelium).
Use:
This test assesses the likelihood of severity of respiratory viral infections, including SARS-CoV-2 coronavirus infection. Regardless of whether or not a person has antibodies to a viral agent, there still remains likelihood of getting sick. As practice has already shown, the course of the disease can vary in different cases. The risks of complications, the development of post-COVID syndrome remain, and, depending on the final risk assessment, the treatment strategy can be changed.
Advantages:
The kit is designed for genotyping human DNA for 10 polymorphisms in order to identify genotypes associated with the risk of severe COVID-19.
The matrix for setting up PCR is human genomic DNA isolated from peripheral blood or other biological material (for example, buccal epithelium).
Use:
This test assesses the likelihood of severity of respiratory viral infections, including SARS-CoV-2 coronavirus infection. Regardless of whether or not a person has antibodies to a viral agent, there still remains likelihood of getting sick. As practice has already shown, the course of the disease can vary in different cases. The risks of complications, the development of post-COVID syndrome remain, and, depending on the final risk assessment, the treatment strategy can be changed.
Advantages:
- 8 points - genetic targets.
- This genetic test has no analogues in the Russian Federation.
- The duration of the test is from 1 hour.
- It is possible to quickly gain an understanding of the treatment tactics from the first moment of obtaining the result.
- Beneficial for doctor and patient.
- The ability to quickly assess the severity of the disease and the risks of complications.
- The information obtained during the genetic study does not change throughout life, and the result displayed in the final report of the patient is also relevant in the case of subsequent cases of respiratory infection, including all variations of the coronavirus strains.
- Master mix for PCR-1 - 2700 µl (2 tubes of 1350 µl)
- Master mix for PCR-2 - 320 µl (1 tube)
- Water without nucleases - 2100 µl (2 tubes of 1050 µl)
- Primer Mix #1 for Polymorphism Analysis #1 - 55 µl (1 tube)
- Primer Mix #2 for Polymorphism Analysis #2 - 55 µl (1 tube)
- Primer Mix #3 for Polymorphism Analysis #3 - 55 µl (1 tube)
- Primer Mix #4 for Polymorphism Analysis #4 - 55 µl (1 tube)
- Primer Mix #5 for Polymorphism Analysis #5 - 55 µl (1 tube)
- Primer Mix #6 for Polymorphism Analysis #6 - 55 µl (1 tube)
- Primer Mix #7 for Polymorphism Analysis #7 - 55 µl (1 tube)
- Primer Mix #8 for Polymorphism Analysis #8 - 55 µl (1 tube)
- Primer Mix #9 for Polymorphism Analysis #9 - 55 µl (1 tube)
- Primer Mix #10 for Polymorphism Analysis #10 - 55 µl (1 tube)
Click here to view
To place an order for a test system, fill out the form. Orders are accepted for legal entities.
By clicking on the "Submit" button, you consent to the processing of personal data processing of personal data
SBT-DX-SARS-CoV-2 RNA REAL DRY
SBT-DX-SARS-CoV-2 FAST COLOR
Набор реагентов для выявления и выделения РНК коронавируса SBT-DX-SARS-CoV-2
Экспресс тест предназначен для детекции вируса SARS-CoV-2 в лабораторных условиях.
Заказать
See also:
The highly accurate test enables real-time RT-PCR testing.
SBT-DX-SARS-CoV-2 (RT-PCR)
A reagent kit for the viral RNA extraction/isolation
SBT-ViralRNA
Reagent kit for extraction and detection of SARS-CoV-2 coronavirus RNA.
SBT-DX-SARS-CoV-2 RNA REAL
A reagent kit for the detection of the most common viral strains that cause respiratory diseases.
SBT-DX-VIRAL Respiratory Panel
The express test is designed to detect the SARS-CoV-2 virus in the laboratory.
SBT-DX-SARS-CoV-2 FAST COLOR
Product line for personal identification and establishment of relationship
SBT-RealGene
We use cookies!
Cookie Settings
Cookies are used to provide a simple and efficient service to the users, browsing the pages
Sistema-BioTech LLC, 109 235, Moscow, st. 1st Kuryanovskaya, 34, building 11, fl. 5
Information on the site is not a public offer
License No. LO-77-01-021 654 dated 2021
License No. 77.01.13.001.L.000097.12.21 dated 2021
Address
Telephone
